Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. Inflammation and NF-kappaB in Alzheimer’s disease and diabetes. J Alzheimers Dis. 2009;16(4):809–21.
Singh B, Kumar A, Singh H, Kaur S, Arora S, Singh B. Protective effect of vanillic acid against diabetes and diabetic nephropathy by attenuating oxidative stress and upregulation of NF-kappaB, TNF-alpha and COX-2 proteins in rats. Phytother Res. 2022;36(3):1338–52.
Article CAS PubMed Google Scholar
Baig N, Sultan R, Qureshi SA. Antioxidant and anti-inflammatory activities of Centratherum anthelminticum (L.) Kuntze seed oil in diabetic nephropathy via modulation of Nrf-2/HO-1 and NF-kappaB pathway. BMC Complement Med Ther. 2022;22(1):301.
Article CAS PubMed PubMed Central Google Scholar
Xu F, Zha G, Wu Y, Cai W, Ao J. Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. 2018;11:8855–63.
Article CAS PubMed PubMed Central Google Scholar
Pandey A, Ajgaonkar S, Jadhav N, Saha P, Gurav P, Panda S, Mehta D, Nair S. Current Insights into miRNA and lncRNA Dysregulation in Diabetes: Signal Transduction, Clinical Trials and Biomarker Discovery. Pharmaceuticals (Basel) 2022, 15(10).
Xiao Y, Xiao T, Ou W, Wu Z, Wu J, Tang J, Tian B, Zhou Y, Su M, Wang W. LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers. Biomark Res. 2020;8:41.
Article PubMed PubMed Central Google Scholar
Yang M, Wei W. SNHG16: a Novel Long-Non coding RNA in human cancers. Onco Targets Ther. 2019;12:11679–90.
Article CAS PubMed PubMed Central Google Scholar
Jiang X, Ru Q, Li P, Ge X, Shao K, Xi L, Xu B, Wang Q, Huang S. LncRNA SNHG16 induces proliferation and fibrogenesis via modulating mir-141-3p and CCND1 in diabetic nephropathy. Gene Ther. 2020;27(12):557–66.
Article CAS PubMed Google Scholar
He X, Zeng X. LncRNA SNHG16 aggravates high Glucose-Induced Podocytes Injury in Diabetic Nephropathy through Targeting miR-106a and thereby Up-Regulating KLF9. Diabetes Metab Syndr Obes. 2020;13:3551–60.
Article CAS PubMed PubMed Central Google Scholar
Huang L, Xiong S, Liu H, Li M, Zhang R, Liu Y, Hu X. Bioinformatics Analysis of the Inflammation-Associated lncRNA-mRNA coexpression network in type 2 diabetes. J Renin Angiotensin Aldosterone Syst. 2023;2023:6072438.
Article PubMed PubMed Central Google Scholar
Kraczkowska W, Stachowiak L, Plawski A, Jagodzinski PP. Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences? J Appl Genet. 2022;63(2):293–303.
Article CAS PubMed PubMed Central Google Scholar
Wu D, Zhu J, Fu Y, Li C, Wu B. LncRNA HOTAIR promotes breast cancer progression through regulating the miR-129-5p/FZD7 axis. Cancer Biomark. 2021;30(2):203–12.
Article CAS PubMed Google Scholar
Wang H, Mou H, Xu X, Liu C, Zhou G, Gao B. LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-kappaB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis. Bioengineered. 2021;12(2):11353–68.
Article CAS PubMed PubMed Central Google Scholar
Lv Z, Ye S, Wang Z, Xin P, Chen Y, Tan Z, Zhuang Y. Long non-coding RNA TSPEAR antisense RNA 2 is downregulated in rheumatoid arthritis and inhibits the apoptosis of fibroblast-like synoviocytes by downregulating microRNA-212-3p (miR-212-3p). Bioengineered. 2022;13(2):4166–72.
Article CAS PubMed PubMed Central Google Scholar
Nong W, Bao C, Chen Y, Wei Z. Mir-212-3p attenuates neuroinflammation of rats with Alzheimer’s disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway. Bosn J Basic Med Sci. 2022;22(4):540–52.
CAS PubMed PubMed Central Google Scholar
Ko KI, Syverson AL, Kralik RM, Choi J, DerGarabedian BP, Chen C, Graves DT. Diabetes-Induced NF-kappaB dysregulation in skeletal stem cells prevents resolution of inflammation. Diabetes. 2019;68(11):2095–106.
Article CAS PubMed PubMed Central Google Scholar
Xie Z, Wang B, Zheng C, Qu Y, Xu J, Wang B, Gao Y, Shen P. Taraxasterol inhibits inflammation in osteoarthritis rat model by regulating miRNAs and NF-kappaB signaling pathway. Acta Biochim Pol 2022.
Cai F, Jiang H, Li Y, Li Q, Yang C. Upregulation of long non-coding RNA SNHG16 promotes diabetes-related RMEC dysfunction via activating NF-kappaB and PI3K/AKT pathways. Mol Ther Nucleic Acids. 2021;24:512–27.
Article CAS PubMed PubMed Central Google Scholar
Society CD. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus. 2021;13:315–409.
van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA. Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. The Lancet Diabetes & Endocrinology. 2020;8(4):325–36.
Crasto W, Patel V, Davies MJ, Khunti K. Prevention of Microvascular Complications of Diabetes. Endocrinol Metab Clin North Am. 2021;50(3):431–55.
Du S, Guo Y, Huang J, Xu J, Chen G. The Expressions and Functions of lncRNA Related to m6A in Hepatocellular Carcinoma from a Bioinformatics Analysis. Comput Math Methods Med 2022, 2022:1395557.
Ren L, Fang X, Shrestha SM, Ji Q, Ye H, Liang Y, Liu Y, Feng Y, Dong J, Shi R. LncRNA SNHG16 promotes development of oesophageal squamous cell carcinoma by interacting with EIF4A3 and modulating RhoU mRNA stability. Cell Mol Biol Lett. 2022;27(1):89.
Article CAS PubMed PubMed Central Google Scholar
Chen ZY, Wang XY, Yang YM, Wu MH, Yang L, Jiang DT, Cai H, Peng Y. LncRNA SNHG16 promotes colorectal cancer cell proliferation, migration, and epithelial-mesenchymal transition through miR-124-3p/MCP-1. Gene Ther. 2022;29(3–4):193–205.
Article CAS PubMed Google Scholar
Liu Y, Zhang M, Zhong H, Xie N, Wang Y, Ding S, Su X. LncRNA SNHG16 regulates RAS and NF-kappaB pathway-mediated NLRP3 inflammasome activation to aggravate diabetes nephropathy through stabilizing TLR4. Acta Diabetol 2023.
Sun W, Zhang X, He X, Zhang J, Wang X, Lin W, Wang X, Wu X. Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in Mycobacterium tuberculosis-infected macrophages by targeting mir-140-5p expression. Infect Genet Evol. 2022;103:105325.
Article CAS PubMed Google Scholar
Bai L, Gong J, Guo Y, Li Y, Huang H, Liu X. Construction of a ceRNA network in polycystic ovary syndrome (PCOS) driven by exosomal lncRNA. Front Genet. 2022;13:979924.
Article CAS PubMed PubMed Central Google Scholar
Lu Y, Zhao X, Liu Q, Li C, Graves-Deal R, Cao Z, Singh B, Franklin JL, Wang J, Hu H, et al. lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/beta-catenin signaling. Nat Med. 2017;23(11):1331–41.
Article CAS PubMed PubMed Central Google Scholar
Muller V, Oliveira-Ferrer L, Steinbach B, Pantel K, Schwarzenbach H. Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer. Mol Oncol. 2019;13(5):1137–49.
Article PubMed PubMed Central Google Scholar
Zhong J, He C, Xu F, Xu X, Liu L, Xu M, Guo Z, Wang Y, Liao J, Li Y. Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p. J Orthop Surg Res. 2020;15(1):374.
Article PubMed PubMed Central Google Scholar
Wu Z, Yu B, Jiang L. MiR-212-3p mediates apoptosis and invasion of esophageal squamous cell carcinoma through inhibition of the Wnt/beta-catenin signaling pathway by targeting SOX4. J Thorac Dis. 2020;12(8):4357–67.
Article PubMed PubMed Central Google Scholar
Chen W, Bian H, Xie X, Yang X, Bi B, Li C, Zhang Y, Zhu Q, Song J, Qin C, et al. Negative feedback loop of ERK/CREB/miR-212-3p inhibits HBeAg-induced macrophage activation. J Cell Mol Med. 2020;24(18):10935–45.
Article CAS PubMed PubMed Central Google Scholar
Shang B, Xu T, Hu N, Mao Y, Du X. Circ-Klhl8 overexpression increased the therapeutic effect of EPCs in diabetic wound healing via the miR-212-3p/SIRT5 axis. J Diabetes Complications. 2021;35(11):108020.
Article CAS PubMed Google Scholar
Cheng Q, Wang L. LncRNA XIST serves as a ceRNA to regulate the expression of ASF1A, BRWD1M, and PFKFB2 in kidney transplant acute kidney injury via sponging hsa-mir-212-3p and hsa-miR-122-5p. Cell Cycle. 2020;19(3):290–9.
Article CAS PubMed PubMed Central Google Scholar
Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-kappaB pathway and its contribution to beta-cell failure in diabetes. J Mol Endocrinol. 2018;61(2):F1–F6.
Article CAS PubMed Google Scholar
Meng T, Wang J, Tang M, Liu S, Ding L, Yan Y. Diabetes Mellitus promotes atrial structural remodeling and PARP-1/Ikkalpha/NF-kappaB pathway activation in mice. Diabetes Metab Syndr Obes. 2021;14:2189–99.
Article PubMed PubMed Central Google Scholar
Sun L, Ding M, Chen F, Zhu D, Xie X. Breviscapine alleviates podocyte injury by inhibiting NF-kappaB/NLRP3-mediated pyroptosis in diabetic nephropathy. PeerJ. 2023;11:e14826.
留言 (0)